Mixed Adenoneuroendocrine Carcinoma (MANEC) of the Rectum responds to chemotherapy and octreotide: c

来源 :第十二届国际胃癌学术会议 | 被引量 : 0次 | 上传用户:zdjige
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective: To descript a rectal MANEC patients who benefit from systemic chemotherapy as well as octreotide and literatures were reviewed with aim to discuss possible treatments appealing to MANECs.
其他文献
Background: The majority driven mutation of GIST are located in KIT and PDGFRA. A proportion of the remaining 10% of GIST without KIT or PDGFRA mutations called wild type Gastrointestinal Stromal Tumo
Background: Recently, the International Gastric Cancer Association (IGCA) had proposed a new staging system based on a large, worldwide data collection, which demonstrated a better capacity of stratif
Objective: To investigate the clinical characteristics and prognostic factors of patients with gastric mixed adenoneuroendocrine carcinoma(MANEC).